Microfluidic channel-assisted screening of hematopoietic malignancies

Genes Chromosomes and Cancer

Volumn 53, Issue 3, 2014, Pages 255-263

  Mughal, Farah ^a   Baldock, Sara J ^b   Karimiani, Ehsan Ghayoor ^a,c   Telford, Nick ^d   Goddard, Nicholas J ^b   Day, Philip J R ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN;

ARTICLE; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; DENATURATION; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; HEMATOLOGIC MALIGNANCY; HYBRIDIZATION; IMMOBILIZED CELL; LEUKEMIA CELL LINE; MICROFLUIDIC ANALYSIS; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; SCREENING;

CELL SIZE; HEMATOLOGIC NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; JURKAT CELLS; K562 CELLS; MICROFLUIDICS; NEOPLASM, RESIDUAL;

EID: 84892484062     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22137     Document Type: Article

References (28)

1. Anastasi J, Le Beau MM, Vardiman JW, Fernald AA, Larson RA, Rowley JD. 1992. Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: A simple and sensitive method. Blood 79:1796-1801.
2. Baldock SJ, Goddard NJ, Fielden PR. 2000. Fabrication of glass microdevices using a fluorosilicic acid etching technique. Proc of MICRO tec, Germany, pp. 615-620.
3. Barch MJ, editor. 1991. The ACT Cytogenetics Laboratory Manual. New York, NY: Raven Press Inc.
4. Buonamici S, Ottaviani E, Testoni N, Montefusco V, Visani G, Bonifazi F, Amabile M, Terragna C, Ruggeri D, Piccaluga PP, Isidori A, Malagola M, Baccarani M, Tura S, Martinelli G. 2002. Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state. Blood 99:443-449.
5. Cervera Ceballos EE. 2007. Adopting molecular tools for diagnosis and monitoring malignant hematological disease. Cancerologia 2:121-136.
6. Cheng J, Shoffner MA, Hvichia GE, Kricka LJ, Wilding P. 1996. Chip PCR. II. Investigation of different PCR amplification systems in microbabricated silicon-glass chips. Nucleic Acids Res 24:380-385.
7. Day PJR. 2006. Miniaturization applied to analysis of nucleic acids in heterogeneous tissues. Expert Rev Mol Diagn 6:23-28.
8. Devadhasan JP, Kim S, An J. 2011. Fish-on-a-chip: A sensitive detection microfluidic system for Alzheimer's disease. J Biomed Sci 18:1-11.
9. Dolken G. 2001. Detection of minimal residual disease. Adv Cancer Res 82:133-185.
10. Garcia-Marco JA, Price CM, Catovsky D. 1997. Interphase cytogenetics in chronic lymphocytic leukemia. Cancer Genet Cytogenet 94:52-58.
11. Gresham D, Dunham MJ, Botstein D. 2008. Comparing whole genomes using DNA microarrays. Nat Rev Genet 9:291-302.
12. Mainland D, Coady BK. 1938. The investigation of cell size with special reference to the human lymphocyte. J Anat 72:374-398.
13. Manbachi A, Shrivastava S, Cioffi M, Chung BG, Moretti M, Demirci U, Yliperttula M, Khademhosseini A. 2008. Microcirculation within grooved substrates regulates cell positioning and cell docking inside microfluidic channels. Lab Chip 8:747-754.
14. Naumann S, Reutzel D, Speicher M, Decker HJ. 2001. Complete karyotype characterization of the K562 cell line by combined application of G-banding, multiplex-fluorescence in situ hybridization, fluorescence in situ hybridization, and comparative genomic hybridization. Leuk Res 25:313-322.
15. Pine SR, Moy FH, Wiemels JL, Gill RK, Levendoglu-Tugal O, Ozkaynak MF, Sandoval C, Jayabose S. 2003. Real-time quantitative PCR: Standardized detection of minimal residual disease in pediatric acute lymphoblastic leukemia. J Pediatr Hematol Oncol 25:103-108.
16. Rabin K, Man TK, Lau CC. 2008. Personalized care of pediatric cancer patients. Nestle Nutr Workshop Ser Pediatr Program 62:173-185.
17. Sieben VJ, Debes-Marun CS, Pilarski PM, Kaigala GV, Pilarski LM, Backhouse CJ. 2007. FISH and chips: Chromosomal analysis on microfluidic platforms. IET Nanobiotechnol 1:27-35.
18. Sieben VJ, Debes-Marun CS, Pilarski LM, Backhouse CJ. 2008. An integrated microfluidic chip for chromosome enumeration using fluorescence in situ hybridization. Lab Chip 8:2151-2156.
19. Tefferi A, Dewald GW, Lizow ML, Cortes J, Mauro MJ, Talpaz M, Kantarjian HM. 2005. Chronic myeloid leukemia: Current application of cytogenetics and molecular testing for diagnosis and treatment. Mayo Clin Proc 80:390-402.
20. Travlos GS. 2006. Normal structure, function, and histology of the bone marrow. Toxicol Pathol 34:548-565.
21. van der Velden VH, Hochhaus A, Cazzaniga G, Szczepanski T, Gabert J, van Dongen JJ. 2003. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: Principles, approaches, and laboratory aspects. Leukemia 17:1013-1034.
22. VanDijken J, Kaigala GV, Lauzon J, Atrazhev A, Adamia S, Taylor BJ, Reiman T, Belch AR, Backhouse CJ, Pilarski LM. 2007. Microfluidic chips for detecting the t(4;14) translocation and monitoring disease during treatment using reverse transcriptase-polymerase chain reaction analysis of IgH-MMSET hybrid transcripts. J Mol Diagn 9:358-367.
23. Voldman J, Gray ML, Schmidt MA. 1999. Microfabrication in biology and medicine. Annu Rev Biomed Eng 1:401-425.
24. Vorsanova SG, Yurov YB, Iourov IY. 2010. Human interphase chromosomes: A review of available molecular cytogenetic technologies. Mol Cytogenet 3:1-54.
25. Whitesides GM. 2006. The origins and the future of microfluidics. Nature 442:368-373.
26. Wilke R, Buttgenbach S. 2003. A micromachined capillary electrophoresis chip with fully integrated electrodes for separation and electrochemical detection. Biosens Bioelectron 19:149-153.
27. Zanardi A, Bandiera D, Bertolini F, Corsini CA, Gregato G, Milani P, Barborini E, Carbone R. 2010. Miniaturized FISH for screening of onco-hematological malignancies. Biotechniques 49:497-504.
28. Zembutsu H, Yanada M, Hishida A, Katagiri T, Tsuruo T, Sugiura I, Takeuchi J, Usui N, Naoe T, Ohno R. 2007. Prediction of risk of disease recurrence by genome-wide cDNA microarray analysis in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy. Int J Oncol 31:313-322.